A New Era for Cell and Gene Therapy Signals New Market Opportunities

MedCity News·Oct 24

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A new era for cell and gene therapy is underway, indicating potential new market opportunities. This development may bring changes to the industry, although details of the impact are not specified. The emergence of this new era suggests a shift in the field of cell and gene therapy.

Full coverage

A new era of natural killer cell immunotherapy in tumor treatment: latest advances and cutting-edge perspectives from basic research to clinical practice

Frontiers·Apr 13

New Sickle Cell Therapies Highlight Equity Gaps and Treatment Progress

The American Journal of Managed Care® (AJMC®)·Feb 17

Expanded access to daraxonrasib signals ‘dawn of a new era’ in pancreatic cancer treatment

Healio·May 5

FDA Grants Accelerated Approval to Otarmeni Gene Therapy for OTOF-Related Hearing Loss

The Hearing Review·Apr 28

First Gene Therapy Approved for Hearing Loss

MedPage Today·Apr 23

Ultraprecision Targeting of CALR Mutations Signals a New Era in Myelofibrosis Treatment

Pharmacy Times·Feb 5

Is Johnson & Johnson's $1 Billion Cell Therapy Investment a Game Changer

Kavout | AI·Feb 18

Light-guided evolution creates proteins that can switch, sense, and compute

ScienceDaily·Mar 9

View original report at MedCity News ↗

Fetching the latest headlines…